Bank of America
DFTX

Bank of America’s Definium Therapeutics DFTX Stock Holding History

Bank of America’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,667
Closed -$138K – 8279
2021
Q2 		$138K Buy
+2,667
New +$140K ﹤0.01% 6321

Other funds holding DFTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America's DFTX Position: Q1 2026 in Review

Bank of America increased its Definium Therapeutics (DFTX) stake by 43% in Q1 2026, buying an estimated $812K and bringing the position to 158,345 shares worth $2.99M. The position accounts for ﹤0.01% of the portfolio, ranked #3835.

Bank of America first reported a position in DFTX in Q2 2021 and has held it in 20 quarters since. 247 funds tracked by Wall St. Rank hold DFTX as of Q1 2026.

  • Bank of America held 158,345 shares of Definium Therapeutics worth $2.99M as of Q1 2026.
  • Bank of America bought 47,878 Definium Therapeutics shares in Q1 2026, an estimated $812K.
  • Definium Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #3835 holding.
  • Bank of America first reported a position in Definium Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 247 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.